We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$282M
AUM Growth
+$52.2M
Cap. Flow
-$11.2M
Cap. Flow %
-3.97%
Top 10 Hldgs %
53.18%
Holding
123
New
20
Increased
19
Reduced
30
Closed
30

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$2.1M
2
ALT icon
Altimmune
ALT
+$1.99M
3
PFE icon
Pfizer
PFE
+$1.94M
4
PSFE icon
Paysafe
PSFE
+$1.38M
5
F icon
Ford
F
+$1.2M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$3.33M
2
ABBV icon
AbbVie
ABBV
+$2.82M
3
T icon
AT&T
T
+$1.96M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.83M
5
GLD icon
SPDR Gold Trust
GLD
+$1.7M

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.86%
2 Healthcare 30.79%
3 Technology 11.75%
4 Communication Services 8.8%
5 Financials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
101
DELISTED
Esperion Therapeutics
ESPR
– –
-17,286
Closed -$485K
F icon
102
CALL
Ford
F
$54.8B
– –
-20,000
Closed -$245K
KYNB
103
Kyntra Bio
KYNB
$30.5M
– –
-685
Closed -$594K
FMS icon
104
Fresenius Medical Care
FMS
$11.9B
– –
-43,400
Closed -$1.6M
FXI icon
105
CALL
iShares China Large-Cap ETF
FXI
$4.08B
– –
-8,000
Closed -$373K
GILD icon
106
CALL
Gilead Sciences
GILD
$185B
– –
-5,000
Closed -$323K
GILD icon
107
PUT
Gilead Sciences
GILD
$185B
– –
-10,000
Closed -$646K
IBB icon
108
CALL
iShares Biotechnology ETF
IBB
$10.5B
– –
-5,000
Closed -$753K
IBB icon
109
PUT
iShares Biotechnology ETF
IBB
$10.5B
– –
-35,000
Closed -$5.27M
LOW icon
110
Lowe's Companies
LOW
$109B
– –
-7,500
Closed -$1.43M
NVDA icon
111
CALL
NVIDIA
NVDA
$5.29T
– –
-16,000
Closed -$214K
NVDA icon
112
NVIDIA
NVDA
$5.29T
– –
-40,000
Closed -$534K
PG icon
113
PUT
Procter & Gamble
PG
$342B
– –
-7,500
Closed -$1.02M
QQQ icon
114
PUT
Invesco QQQ Trust
QQQ
$482B
– –
-23,000
Closed -$7.34M
SPCE icon
115
Virgin Galactic
SPCE
$467M
– –
-925
Closed -$567K
SPY icon
116
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$804B
– –
-5,000
Closed -$1.98M
TBT icon
117
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$309M
– –
-9,500
Closed -$207K
TDC icon
118
Teradata
TDC
$2.73B
– –
-7,500
Closed -$289K
TGT icon
119
Target
TGT
$72B
– –
-5,000
Closed -$990K
UVXY icon
120
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$291M
– –
-15
Closed -$206K
UVXY icon
121
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$291M
– –
-5
Closed -$75K
VZ icon
122
CALL
Verizon
VZ
$202B
– –
-12,500
Closed -$727K
VBIV
123
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-867
Closed -$81K
1 2 3 4
5

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, DCF Advisers held 123 positions worth $282M, up 23% from $230M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

DCF Advisers withdrew a net $11.2M in Q2 2021, closing 30 positions and reducing 30 holdings. Its most notable exit was CVS Health, an estimated $1.62M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, DCF Advisers opened a new position in Altimmune worth $1.44M.

  • DCF Advisers's largest Q2 2021 buy was Altimmune: 145,750 shares worth $1.44M.
  • DCF Advisers added most to VanEck Gold Miners ETF in Q2 2021, an estimated $2.1M increase.
  • DCF Advisers's biggest Q2 2021 reduction was Oracle, cutting an estimated $3.33M.
  • DCF Advisers fully exited CVS Health in Q2 2021, selling an estimated $1.62M.
  • DCF Advisers's ten largest holdings make up 53% of its $282M portfolio in Q2 2021.
  • DCF Advisers opened 20 new positions and closed 30 in Q2 2021.
  • DCF Advisers's portfolio value rose 23% quarter-over-quarter to $282M.

Based on DCF Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.